Human papillomaviruses (HPVs) have been detected in urban wastewaters, demonstrating that epitheliotropic viruses can find their way into sewage through the washing of skin and mucous membranes. Papillomavirus shedding through faeces is still an unexplored issue. The objective of the present study was to investigate the presence of HPVs in stool samples. We analysed 103 faecal specimens collected from hospitalized patients with diarrhoea using validated primers able to detect a, b and c HPVs. PCR products underwent sequencing analysis and sequences were aligned to reference genomes from the Papillomavirus Episteme database. A total of 15 sequences were characterized from the faecal samples. Thirteen samples (12.6 %) were positive for nine genotypes belonging to the a and b genera: HPV32 (LR, a1), HPV39 (HR, a7), HPV44 (LR, a10), HPV8 (b1), HPV9, HPV23, HPV37, HPV38 and HPV120 (b2). Two putative novel genotypes of the b genus, species 1 and 2, were also detected. The tissue(s) of origin is unknown, since faeces can collect HPVs originating from or passing through the entire digestive system. To our knowledge, this is the first investigation on the occurrence and diversity of HPVs in faecal samples. Results from this study demonstrate that HPVs can find their way into sewage as a consequence of shedding in the faeces. This highlights the need for further studies aimed at understanding the prevalence of HPV in different water environments and the potential for waterborne transmission.
INTRODUCTION
Papillomaviruses (PVs) are a large family of viruses that infect skin and mucosal epithelia of vertebrates, including humans (HPV). Infections caused by most HPVs are subclinical; the spectrum of diseases ranges from prolific benign lesions such as common warts, to malignant carcinomas of the cervix, vulva, vagina, penis and anus (Bouvard et al., 2009; IARC, 2007) . Worldwide, HPV infections have been linked to several cancers, including lung, breast, ovary, prostate, urinary bladder, urethra and colon rectal cancer, although data on the association between viruses and cancer are still controversial. Recently, two systematic reviews and meta-analysis have strongly supported the hypothesis that some high-risk HPVs are risk factors for colorectal cancers or for a subset of them (Baandrup et al., 2014; Damin et al., 2013) . The viruses also invade human epithelial cells of the oral mucosa, oesophagus, larynx, trachea and conjunctiva of the eye. Today, it is well established that PVs cause a substantial proportion of head and neck cancers (D'Souza & Dempsey, 2011) . The association between HPV infections and skin cancer is still a matter of debate, although increasing evidence supports their role in the development of nonmelanoma skin cancer (Schiller & Buck, 2011; zur Hausen, 2009 ).
In spite of nearly 30 years of studies on PVs, only a small number of them are known in depth, compared with the huge number of PVs identified and sequenced so far. In fact, 176 HPVs have been completely sequenced and officially designated. These are divided into five genera according to the phylogenetic relationship of their L1 ORF: alpha (a), beta (b), gamma (c), mu (m) and nu (n) (de Villiers, 2013) . Hundreds of putative novel HPVs have recently been identified in mucosa and skin by innovative and advanced technologies in DNA sequencing and bioinformatics (Chouhy et al., 2013a) .
Recently, HPV has been detected in sewage and sewage sludge (Bibby & Peccia, 2013; Cantalupo et al., 2011; Symonds, 2008) . Unexpectedly, a wide range of cutaneous (HPV9, HPV20, HPV25, HPV76, HPV80, HPV104, HPV110, HPV111, HPV120 and HPV145) and mucosal (HPV16, HPV6 and HPV11) types have also been detected in the majority of raw sewage samples collected in Italy (81 %) (Fratini et al., 2014; La Rosa et al., 2013 ). These results demonstrate that, like enteric viruses, epitheliotropic viruses can find their way into sewage, and consequently may reach waters receiving sewage discharge. HPVs may end up in sewage, usually through the washing of skin and mucous membranes and also as a result of shedding in the urine. Whether and to what extent they can also be excreted by means of faeces is still unknown.
The objective of the present study was to investigate the presence of HPVs in faecal samples through the analysis of stool specimens obtained from hospitalized patients with clinical signs of diarrhoea of unknown aetiology.
RESULTS
DNA extracts from 103 stool specimens were analysed by five different nested PCRs, using validated broad-range primers in the L1 major capsid coding region (methods A, B, E and F) and in the E1 helicase gene (method D), able to detect a, b and c HPVs.
Results of PCR and genotyping by sequencing are summarized in Table 1 , which reports sample ID numbers, PCR results, the most closely related HPV prototype and the percentage of nucleotide identity. Thirteen DNA samples were HPV-positive (12.6 %), combining the five methods. Two of these samples (IDs 229 and 236) were positive by two different assays. A total of 15 sequences were characterized from the faecal samples.
Five samples were positive with method A, which employs the most commonly used PCR primer sets MY09/MY11 and GP5+/GP6+, specific for anogenital HPVs, and the sequences obtained showed 100 % nucleotide identity with HPV32 (a1, two samples), HPV44 (a10) and HPV120 (b2, two samples) Papillomavirus Episteme database (PaVE) prototypes (Table 1) .
Eight samples were positive with method E, using primers CP65/CP70 and CP66/CP69, specific for cutaneous HPVs. Of these, five showed .90 % identity with PaVE prototypes, and were classified as HPV9 (b2), HPV23 (b2, two samples), HPV38 (b2) and HPV39 (a7).
Sequences detected in samples ID 225 and 239 showed ,87 % nucleotide identity with the HPV124 and HPV15 PaVE prototypes (Table 2) , thus making it impossible to assign these sequences to known genotypes. Conversely, sequence comparison with the GenBank database showed greater matches with some partial HPV sequences: sample 225 showed 99 % nucleotide identity with a sequence detected from the head and neck region (HG326198, 13-JUN-2013, Slovenia) , and with a sequence isolated from recurrent scar carcinoma (AF019978, 18-AUG-1997, Australia), both submitted as non-characterized sequences. Sample 239 showed 99 % nucleotide identity with accession number GQ916646, a sequence identified in an epithelial lesions of cats in the USA in 2001, and 98 % identity with a putative new type detected in normal skin of immunocompetent hosts in Germany (AJ001060) (Astori et al., 1998) .
Three samples were positive by method D, using the PMA/ PMB primers designed in the helicase E1 region ( Table 1) . Two of these, ID 215 and ID 238, showed nucleotide identity .98 % with HPV37 (b2) and HPV8 (b1) PaVE prototypes, respectively. The third sample, ID 229, showed only 90 % nucleotide identity with more than one prototype, such as HPV9, HPV107, HPV159, HPV113 and HPV104; the genotype was therefore not assigned.
No positive samples were detected by method F using the c-PV generic primers E1Gamma-F/E1Gamma-R.
DISCUSSION
The aim of this study was to analyse the presence of HPVs in stool samples collected from patients with clinical signs of diarrhoea of unknown aetiology. As far as we know, this is the first study aimed at investigating the occurrence and diversity of HPVs in human faecal samples. In fact, numerous studies have detected HPVs in anal-rectal cytology specimens, as well as from human colon-rectal mucosa biopsies (Bean & David, 2010 ), but none specifically tested for HPVs in faeces. Our results show that a plethora of a and b HPVs, not all known to cause anogenital papillomatosis, are present in these specimens, paving the way to a new field of investigation. Faecal samples may represent a rich matrix for the study of HPVs in microbiota, since they can collect viruses and genomes present in the entire digestive tract system, from the alimentary canal (oral cavity, pharynx and oesophagus) to the stomach, and small and large intestine. Moreover, faeces analysis is a non-invasive method to investigate potentially dangerous agents such as oncogenic viruses in the gut. The results of the present work show that a broad spectrum of mucosal and cutaneous HPVs are present in 12.6 % of the stools analysed. This percentage might be underestimated owing to PCR failure as a consequence of the low viral load of HPV in human faeces. Indeed, stool samples were collected in the framework of a study on noroviruses; since these viruses are excreted at high concentrations (up to 10 8 g
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) in faeces, very small quantities of samples were collected for the study. Moreover, the PCR methods used in this work could have failed to detect all the HPVs present in faecal samples, some would not be recognized by the broad-range primers currently available. Furthermore, it is important to note that inefficient extraction and incomplete removal of inhibitors may have reduced the sensitivity of the molecular assays. The extraction system employed in this study, which uses BOOM technology, is a gold standard for the universal extraction of RNA and DNA, and ensures purity and quality of nucleic acids (Shulman et al., 2012) . Some of the negative samples were positive for other viruses (noroviruses and rotaviruses; data not shown), attesting to the good quality of the extraction. However, since we did not use an internal control, we cannot exclude inefficient extraction or presence of inhibitors causing false-negative results. For all these reasons, the collection of faecal samples could contain an even larger quantity of HPVs, possibly including prototypes of new species, unable to be detected in our conditions.
Of the 13 positive samples, 6 were collected from female and 7 from male patients, with a median age of 50 years. Patients were hospitalized for different reasons (leukaemia, renal transplantation, abdominal pain, hypertension, Parkinson's disease, pelvic mass); two of these patients were immuno-suppressed.
Sequence analysis revealed the presence of nine different HPVs belonging to the a and b genera, two of which remained unassigned. Moreover, in two samples, two genotypes were simultaneously detected. Three a genotypes, namely HPV32 (LR, a1), HPV39 (HR, a7) and HPV44 (LR, a10), were detected by MY and GP primers. HPV32 is the most common HPV found in the oral cavity and is often found in the warts of HIV (human immunodeficiency virus)-positive individuals; it is also one of the aetiological agents of focal epithelial hyperplasia, a rare and benign papillomatosis disease of the oral cavity (Herrel et al., 2009) . HPV39 is a high-risk genotype classified among the a7 species. A Spanish study found that infection with HPV39 is the only independent predictor of anal intra-epithelial neoplasia grade 2 or 3, or anal cancer, among HIV-positive men who have sex with men (Mascolini, 2013) . HPV44 is associated with condylomata and low-grade cervical changes such as mild dysplasia, and causes anal warts; the occasional role of this low-risk HPV in anogenital carcinoma has been demonstrated (Guimerà et al., 2013) .
Most of the genotypes detected were of the b2 species (HPV9, HPV23, HPV37, HPV38 and HPV120), which comprises viruses with heterogeneous niches, including the oral cavity, eyebrow hairs, peri-anal tissues and skin (Bottalico et al., 2012; Schneider et al., 2013) . HPV23 and HPV38 infections show a positive association with cutaneous squamous cell carcinoma (Iannacone et al., 2014) .
HPV8, the only member of the b1 genus detected in our samples, is a cutaneous HPV clearly involved in skin cancer development in epidermodysplasia verruciformis patients, and its early genes E2, E6 and E7 have been implicated in cell transformation in vitro (Schaper et al., 2005) .
Subgenomic fragments from novel putative genotypes were detected in two samples (IDs 222 and 239). We were not able to amplify longer fragments or the entire genome of the putative novel types, despite the use of different approaches, most probably owing to the low concentration of viruses in faeces (data not shown). The most closely related HPVs, with the highest coverage in the BLAST database, were all from the b genus (species 1 and 2). The unclassified sequence detected in sample ID 239 showed 99 % nucleotide identity with a sequence identified in epithelial lesions of cats in the USA. Previous studies detected PV neoplastic malignant lesions in cats (Lange et al., 2009) . Although it is commonly held that PVs coevolve with their host and that PVs are highly speciesspecific, results from a recent study on bat HPVs suggest otherwise (García-Pérez et al., 2014) . Indeed, sequences related to bovine and human PVs have been found in cats, suggesting cross-species transmission (Egberink et al., 2013) . In the last few years, a large number of new PVs have been isolated from faeces/rectal samples of animals (rat, mouse and penguin) (Phan et al., 2011; Shulz et al., 2012; Varsani et al., 2014) , particularly following the advent of next-generation DNA sequencing techniques. The risk of contracting HPV diseases for people in close contact with pets and other animals, although not yet demonstrated, cannot be excluded.
To our knowledge, this is the first demonstration that a wide spectrum of established and putative HPVs of the a and b genera are present in human stool samples. The tissues of origin are unknown, since faeces can collect PVs originating from or passing through the entire digestive system from the alimentary canal to the stomach and intestine, and to the anus. The most likely origin for HPVs detected in this study is the anal canal. Anal HPV infections are commonly acquired diseases. However, HPV genotypes detected in human faecal samples are not those typically present in anal infections; indeed, we believe that other tissues of origin, like mouth and gut, cannot be excluded. A recent study showed by metagenomic analysis that a complex HPV community is present in a cohort of healthy human subjects. The overall HPV prevalence was 68.9 % and was highest in the skin (61.3 %), followed by vagina (41.5 %), mouth (30 %) and gut (17.3 %) (Ma et al., 2014) . HPVs present in the mouth or in the gut can be eliminated with faeces. A comprehensive knowledge about HPV tissue tropism might contribute to our understanding of the evolution of HPV genera and genotypes.
Results from this study confirm that epitheliotropic viruses, including tumour viruses, can find their way into sewage, not only through the washing of skin and mucous membranes, but also as a result of shedding in the faeces. This highlights the need for further studies aimed at understanding the significance of the prevalence of HPVs in raw sewage and in other water environments in terms of the possibility of waterborne transmission (Fratini et al., 2014) . The possibility that environmental contamination with oncogenic HPVs could be a factor influencing morbidity of both HPV infections and associated cancers is challenging.
METHODS
Clinical samples. A total of 103 samples were analysed, collected at the A. Gemelli Hospital, Catholic University Medical School of Rome, Italy, from patients with symptoms of diarrhoea, hospitalized during 2011 and 2012. These samples (one per patient) had been collected previously in the framework of a study on enteric viruses (Muscillo et al., 2013) . All precautions were adopted to prevent contamination at collection. Of the 103 samples, 59 were from female and 44 from male patients; the median age of the patients was 50 years, ranging from 3 to 91 years.
Total nucleic acid was extracted using the automated platform Nuclisens Easymag (bioMérieux), according to the manufacturer's instructions. After the extraction, DNA was aliquoted, stored at 280 uC and thawed only once.
PCR assays and sequencing. Samples were analysed by five nested PCR assays able to detect cutaneous and mucosal HPVs: method Aprimers MY09/MY11 (first round), followed by GP5+/GP6 and GP5+/MY09 (nested and eminested, respectively); method Bprimers FAP59/FAP64 (first round) followed by FAP6085/FAP6319 (nested); method D -primers PM-A/PM-B (used for both first and second cycles). PCR conditions were as previously described (Di Bonito et al., 2006; La Rosa et al., 2013) . Primers and references for all methods used are shown in Table 2 .
Two other methods, here called method E and method F, were used in this work to increase the chance of detecting b and c HPVs. Method E used the CP65/CP70 primers followed by the CP66/CP69 primers. In the first cycle, a 10 min denaturation step at 95 uC was followed by five cycles, each consisting of 1 min at 95 uC, 1.5 min at 50 uC and 2 min at 72 uC, and then by 35 cycles of 1 min at 95 uC, 1 min at 55 uC and 2 min at 72 uC. The second reaction was performed using the following temperature parameters: 30 cycles (1 min at 95 uC, 1 min at 55 uC and 2 min at 72 uC) after a 10 min denaturation step at 95 uC. Method F used c-PV generic primers E1Gamma-F/E1Gamma-R in double consecutive PCR amplification. A PostgreSQL database was previously created to keep track of all the primers, PCR products and samples used; an internet connection to this database is available for registered users at https://cosmos.bio. uniroma1.it. The primers used in the study are shown in Table 2 , along with their sequences, and the amplicon lengths generated.
For each PCR, 2 ml of extracted DNA and 22 pmol of each primer were used in a final mixture of 25 ml, using the MyTaqTM Red Mix PCR kit (Bioline). The products of the first round of amplification were then subjected to a second round using 2 ml of the first-step PCR as input. All standard precautions, adhering to strict laboratory practice, were followed to prevent any contamination because of the extreme sensitivity of PCR. Different steps, such as DNA extraction, sample preparation, amplification and post-PCR, were performed in strictly separated rooms. The negative PCR control included all PCR components without template DNA.
Positive controls were also included in each PCR for the verification of negative amplification results, consisting of HPV DNAs detected previously in wastewater samples (La .
All positive results were confirmed by repeating both PCR and sequencing, with identical results. Following amplification, positive PCR products were purified using a Montage PCRm96 Micro-well Filter Plate (Millipore) and purified amplicons were directly sequenced with a capillary automatic sequencer (Bio-Fab Research), employing the forward and reverse primers used for the amplification.
Genotyping. All sequences were submitted to BLAST analysis for genotyping against prototype sequences of the Papillomavirus Episteme database (PaVE) (http://pave.niaid.nih.gov/) and, as a control, against sequences of the NCBI GenBank database (http:// blast.ncbi.nlm.nih.gov/Blast.cgi). The HPV genotype was assigned when the sequence showed a percentage nucleotide identity higher than 90 % toward a known prototype in PaVE ( 
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